MRI system significantly improves prostate cancer detection and efficiency. Find out how ProAI boosts accuracy and reduces ...

In this episode, Nicolas Girard discusses the latest developments in non-small cell lung cancer (NSCLC), with a focus on new ...

Phase 3b WAYFINDER data show tezepelumab oral corticosteroid reduction in severe asthma, with nearly 90 percent reaching 5 mg ...

Over half of patients with severe asthma discontinued oral corticosteroids while maintaining disease control, major study ...

Plexiform neurofibromas (PNF) are benign, often infiltrative tumours of the peripheral nerve sheath classically linked to ...

Hepatocellular carcinoma (HCC) is the sixth leading cause of cancer-related mortality worldwide.1 Despite therapeutic ...

Over the past two decades, thoracic oncology has undergone a profound transformation, moving from limited chemotherapy ...

Sexually transmitted infections (STI) have a disproportionately high prevalence in individuals in custody and persons with ...

Congress 2025 took place in Berlin, Germany, a dynamic epicentre known for its blend of innovation, culture, and historical ...

The following highlights showcase key research presented at the European Society for Medical Oncology (ESMO) 2025 Congress.

EMJ's latest Oncology Journal is now available, covering everything you need to know from ESMO 2025 and beyond. Inside, ...

A simple blood test analysed by artificial intelligence could revolutionise early detection of primary vitreoretinal lymphoma ...